With a turnover up by 8.1% in the first six months of 2022, pharmacies are the undisputed protagonists ofthe Italian health market. Today they are affected by a twofold process of transformation: in terms of governance, with the entry of corporations and the growing spread of chains, and in terms of business, less dispensers of medicines and more providers of diagnostic and digital services.

This scenario is triggered on a network of pharmacies that in Italy is very widespread, but also suffers dimensional delays compared to the main European countries.

The Report dedicated to the pharmacy sector represents the third chapter of a series of studies related to the Health Supply Chain (the others: Nutraceuticals and MedTech).